In the late stages, this compensatory mechanism may become maladaptive from the loss of renal functions, resulting in a progressive increased FGF23 level, decreased calcitriol levels, hypocalcemia, and associated consequences such as CKD-MBD from a secondary hyperparathyroidism. This evidence concerns the gene FGF23 and Marchiafava-Bignami disease.